InvestorsHub Logo
Followers 155
Posts 2683
Boards Moderated 0
Alias Born 01/29/2004

Re: TC65 post# 141133

Thursday, 02/15/2018 10:28:13 AM

Thursday, February 15, 2018 10:28:13 AM

Post# of 471591
Two For Three

The FDA recognizes the urgent need for new medical treatments for many serious conditions including neurological disorders such as muscular dystrophies, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD), migraine and epilepsy.



Ok, the new FDA perspective includes two Anavex targets. (Epilepsy is a feature of Rett syndrome.)

Didn't, yet, include Parkinson's, our third target.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News